Q4 2011 · 10-K
Revenue$32.15M$32.15M +91.7% vs Q4 2010+163.2% vs Q3 2011
Net Income-$6.97M-$6.97M N/M vs Q4 2010N/M vs Q3 2011
EPS Diluted-$0.07-$0.07 N/M vs Q4 2010N/M vs Q3 2011
Operating Incomederived-$7,032,000—
Operating Cash Flowderived-$7,701,000N/M
Free Cash Flowderived-$11,350,000N/M
Margins · derived
Operating margin-21.9%
Net margin-21.7%+47.8 pt vs Q4 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2011 | Q4 2010 |
|---|---|---|
| Revenue | $32.15M | $16.77M |
| Net Income | -$6.97M | -$11.65M |
| EPS Diluted | -$0.07 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR